Latest Period
Q2 2026
Security Snapshot
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) Institutional Ownership
CUSIP: 69353Y103
13F Institutional Holders and Ownership History from Q3 2020 to Q2 2026
Institutions Reporting
63
Shares (Excl. Options)
34,280,762
Price
$1.34
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.00001 per share
- Symbol
- PMVP on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 34,280,762
- Total 13F value
- $45,929,055
- Portfolio coverage rank
- 0%
- Share change
- -2,680,778
- Value change
- -$3,508,262
- Number of holders
- 63
- Shares outstanding
- 53,322,611
- SEC-reported price per share
- $1.34
- Insider filing price
- $1.34
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share is tracked under CUSIP 69353Y103.
- 63 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 69 to 63 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $45,836,259 to $45,929,055.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 63 institutions filings for Q2 2026.
Security key
69353Y103
Latest holder period
Q2 2026
13F holders
63
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
PMVP full holder history
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
PMV Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 69353Y103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
PMVP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.9% | +60% | $6,615,000 | +$2,527,616 | 5,292,000 | +62% | BML Investment Partners, L.P. | 31 Dec 2025 |
| TANG CAPITAL MANAGEMENT LLC | 8.9% | $6,702,907 | 4,720,357 | TANG CAPITAL MANAGEMENT, LLC | 16 Sep 2025 | |||
| Sio Capital Management, LLC | 4.9% | -14% | $3,398,037 | -$570,751 | 2,634,137 | -14% | Sio Capital Management, LLC | 30 Jun 2026 |
| Euclidean Capital LLC | 4.9% | $3,284,554 | 2,627,643 | Euclidean Capital LLC | 31 Mar 2026 | |||
| ArrowMark Colorado Holdings LLC | 3.7% | -36% | $2,625,836 | -$1,514,889 | 1,959,579 | -37% | ArrowMark Colorado Holdings, LLC | 30 Jun 2026 |
As of 30 Jun 2026, 63 institutional investors reported holding 34,280,762 shares of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP). This represents 64% of the company’s total 53,322,611 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
62%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 10% | 5,330,000 | +0.19% | 4.1% | $7,142,200 |
| TANG CAPITAL MANAGEMENT LLC | 8% | 4,245,085 | 0% | 0.26% | $5,688,414 |
| Sio Capital Management, LLC | 4.9% | 2,634,137 | -14% | 0.6% | $3,529,744 |
| Euclidean Capital LLC | 4.9% | 2,627,643 | 0% | 0.8% | $3,521,042 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.4% | 2,360,000 | +27% | 0% | $3,162,400 |
| ACADIAN ASSET MANAGEMENT LLC | 4.2% | 2,215,894 | 0% | 0% | $2,968,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 2,012,020 | +1.9% | 0% | $2,696,107 |
| ArrowMark Colorado Holdings LLC | 3.7% | 1,959,579 | -32% | 0.11% | $2,625,836 |
| TWO SIGMA INVESTMENTS, LP | 3.7% | 1,954,136 | +3.7% | 0% | $2,618,542 |
| Eversept Partners, LP | 3.5% | 1,890,904 | -19% | 0.14% | $2,533,811 |
| BlackRock, Inc. | 1.7% | 919,818 | +5.2% | 0% | $1,232,556 |
| Stonepine Capital Management, LLC | 1% | 536,086 | -24% | 0.55% | $718,355 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.89% | 473,158 | -4.6% | 0% | $634,624 |
| Aldebaran Capital, LLC | 0.88% | 467,432 | -1.3% | 0.47% | $626,359 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.8% | 428,853 | 0% | 0.01% | $574,663 |
| BIT Capital GmbH | 0.76% | 407,555 | +230% | 0.02% | $546,124 |
| Verdad Advisers, LP | 0.68% | 362,361 | +101% | 0.47% | $485,564 |
| Walleye Capital LLC | 0.63% | 335,694 | 0% | 0% | $449,830 |
| Assenagon Asset Management S.A. | 0.62% | 330,003 | -8.5% | 0% | $442,204 |
| MARSHALL WACE, LLP | 0.6% | 321,610 | -26% | 0% | $430,956 |
| VANGUARD FIDUCIARY TRUST CO | 0.48% | 254,775 | -15% | 0% | $341,399 |
| BANK OF AMERICA CORP /DE/ | 0.45% | 240,110 | -0.18% | 0% | $321,747 |
| ADAR1 Capital Management, LLC | 0.38% | 201,008 | -13% | 0.01% | $269,351 |
| STATE STREET CORP | 0.34% | 183,178 | 0% | 0% | $245,459 |
| RBF Capital, LLC | 0.3% | 162,200 | 0% | 0.01% | $217,348 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
24
Latest
Q2 2026
Rows shown
1-24 of 24
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 34,280,762 | $45,929,055 | -$3,508,262 | $1.34 | 63 |
| 2026 Q1 | 36,961,561 | $45,836,259 | -$782,598 | $1.24 | 69 |
| 2025 Q4 | 37,422,687 | $46,777,977 | -$174,801 | $1.25 | 62 |
| 2025 Q3 | 37,492,718 | $52,488,395 | +$4,772,987 | $1.40 | 63 |
| 2025 Q2 | 34,680,709 | $36,758,763 | -$2,911,770 | $1.06 | 52 |
| 2025 Q1 | 37,320,031 | $40,676,123 | -$2,281,115 | $1.09 | 54 |
| 2024 Q4 | 38,959,310 | $58,833,270 | -$767,790 | $1.51 | 70 |
| 2024 Q3 | 39,023,873 | $58,153,846 | -$2,416,795 | $1.49 | 73 |
| 2024 Q2 | 40,492,185 | $65,594,864 | -$3,771,661 | $1.62 | 91 |
| 2024 Q1 | 42,725,320 | $72,627,924 | -$11,853,919 | $1.70 | 96 |
| 2023 Q4 | 46,465,983 | $144,025,863 | -$52,160,467 | $3.10 | 97 |
| 2023 Q3 | 54,236,025 | $333,006,052 | +$15,386,619 | $6.14 | 103 |
| 2023 Q2 | 51,696,984 | $323,689,509 | +$3,281,155 | $6.26 | 104 |
| 2023 Q1 | 51,513,177 | $245,718,220 | -$16,150,590 | $4.77 | 111 |
| 2022 Q4 | 54,555,170 | $474,625,571 | -$38,255,414 | $8.70 | 113 |
| 2022 Q3 | 58,187,852 | $692,436,457 | -$36,596,424 | $11.90 | 116 |
| 2022 Q2 | 61,123,657 | $870,921,498 | +$53,476,878 | $14.25 | 105 |
| 2022 Q1 | 55,249,345 | $1,150,065,944 | +$162,099,243 | $20.82 | 98 |
| 2021 Q4 | 47,470,437 | $1,096,597,184 | +$15,190,740 | $23.10 | 102 |
| 2021 Q3 | 43,990,444 | $1,310,907,931 | +$46,789,977 | $29.80 | 91 |
| 2021 Q2 | 42,241,228 | $1,442,956,792 | +$80,038,413 | $34.16 | 83 |
| 2021 Q1 | 39,915,363 | $1,312,819,295 | +$51,865,975 | $32.89 | 81 |
| 2020 Q4 | 38,212,089 | $2,335,342,669 | +$185,049,476 | $61.51 | 72 |
| 2020 Q3 | 31,212,908 | $1,098,804,001 | +$1,098,804,001 | $35.50 | 51 |